It was certainly a good day for India as two of its top players, Saina Nehwal and RMV Gurusaidutt reached to the semi-finals at the World Junior Badminton Championship.

In a close encounter match, fifth seed Guru Sai Dutt defeated second seed Park Sung Min (Korea) 21-16, 14-21, 21-19. With this win, the 17-year-old Gurusaidutt has became the first Indian male shuttler to reach the semi-finals of the men’s singles.

Ace Bollywood beauty Kareena Kapoor has been appointed as the new brand ambassador of PepsiCo India Holdings (Frito-Lay Divison) to endorse its snack food products.

In a press statement, Kareena said, “It is a privilege to be associated with the brand as it is a big hit among youngsters. I’m excited and looking forward to a long and fulfilling association with the brand.”

Bebo will be seen with loving beau Saif Ali Khan, multi-talented actress Juhi Chawla and flamboyant cricketer Mahendra Singh Dhoni in a new ad campaign for the product.

The Centers for Disease Control and Prevention said diabetes doubled in the last decade, and obesity is the reason for the increase.

Affecting more than 23 million Americans, diabetes is the seventh-leading cause of death in the US, with more than a million and a half new cases diagnosed just last year. The highest rates were seen in the South with West Virginia being the worst hit where 13 in a 1000 adults were diagnosed with the disease in the years 2005-07.  Minnesota was the best off with 5 in a 1000 with the disease.

America’s largest network, Alltel Wireless and Samsung telecommunications America (Samsung) have jointly launched the much-awaited ‘Samsung Delve’ in the US markets.

The stylish Samsung Delve comes up with a spontaneous interface and attractive touchscreen design. The phone boasts a virtual QWERTY keyboard with Samsung’s TouchWiz interface that comprises specially designed gadgets. With this unique feature, users can easily customize and personalize their handsets.

An FDA advisory panel ruled yesterday that the Food and Drug Administration was wrong when it determined that a chemical used in baby bottles and infant formula packing is safe at current levels and the agency should redo its risk assessment.

The FDA Science Board consists of a group of scientists drawn from academia, government and industry that advises the FDA commissioner. Yesterday at a meeting in Gaithersburg, they voted unanimously to accept the report by a subcommittee which linked exposure to low doses of BPA to an increased risk of diabetes, heart disease, hyperactivity and cancer in laboratory animals and that its margin of safety was "inadequate."

The U.S. Food and Drug Administration has approved a new prescription drug, Toviaz (fesoterodine fumarate), to treat overactive bladder in adults. Overactive bladder (OAB) in adults is characterized by urinary frequency and sudden urinary incontinence, Toviaz relaxes the bladders smooth muscle tissue reducing the urge to urinate.

George Benson, MD, deputy director of the Division of Reproductive and Urologic Products at the FDA's Center for Drug Evaluation and Research said, "Patients who suffer from overactive bladder face quality of life issues that can hamper their ability to enjoy life to its fullest. This new drug will provide an additional treatment option to help them manage problems with an overactive bladder."